A Theranostic Approach to HER2 Radio-ADC Precision Medicine Using Affibody Scaffold Technology

Time: 2:00 pm
day: Day One


• HER2-imaging is an attractive tool for characterization of tumor uptake
• High contrast tumor targeting ability demonstrated in patients with metastatic breast cancer
• Lack of tumor uptake in HER2 IHC+ tumor predicted lack of response to conventional HER2 treatment
• Imaging scaffold has been engineered to allow for molecular radiotherapy
• Preclinical molecular radiotherapy data supports clinical translation